Gvb Biopharma

CBD extraction and distillation

Based in NV

🤖

AI Overview

With $570K in lobbying spend across 20 quarterly filings, Gvb Biopharma is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2020 to 2024.

$570K
Total Spend
5
Years Active
1
Firms Hired
7
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$60K
2021$120K
2022$120K
2023$170K
2024$100K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Gvb Biopharma disclosed contacting in their lobbying filings.

Food & Drug Administration (FDA)Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Government Issues, Trade, Postal, Law Enforcement

Issues relating to the import/export of CBD equipment

Monitoring regulations on Hemp/CBD

Issues relating to the distribution of personal protective equipment.

Monitored regulations on hemp/CBD issues.

Discussions relating to the distribution of personal protective equipment.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.